These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25179578)

  • 21. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H; Beeber LS; Schwartz TA; Lewis G
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
    Luciano JV; D'Amico F; Cerdà-Lafont M; Peñarrubia-María MT; Knapp M; Cuesta-Vargas AI; Serrano-Blanco A; García-Campayo J
    Arthritis Res Ther; 2014 Oct; 16(5):451. PubMed ID: 25270426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of Community-Based Depression Interventions for Rural and Urban Adults With Type 2 Diabetes: Projections From Program ACTIVE (Adults Coming Together to Increase Vital Exercise) II.
    Kuo S; Ye W; de Groot M; Saha C; Shubrook JH; Hornsby WG; Pillay Y; Mather KJ; Herman WH
    Diabetes Care; 2021 Apr; 44(4):874-882. PubMed ID: 33608260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
    BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cognitive behavioural therapy for breast cancer: cost-effectiveness demonstrated].
    Kaptein AA
    Ned Tijdschr Geneeskd; 2014; 159():A8504. PubMed ID: 25589284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States.
    Darden M; Espie CA; Carl JR; Henry AL; Kanady JC; Krystal AD; Miller CB
    Sleep; 2021 Apr; 44(4):. PubMed ID: 33151330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.
    Mann E; Smith MJ; Hellier J; Balabanovic JA; Hamed H; Grunfeld EA; Hunter MS
    Lancet Oncol; 2012 Mar; 13(3):309-18. PubMed ID: 22340966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years.
    Tyrer P; Salkovskis P; Tyrer H; Wang D; Crawford MJ; Dupont S; Cooper S; Green J; Murphy D; Smith G; Bhogal S; Nourmand S; Lazarevic V; Loebenberg G; Evered R; Kings S; McNulty A; Lisseman-Stones Y; McAllister S; Kramo K; Nagar J; Reid S; Sanatinia R; Whittamore K; Walker G; Philip A; Warwick H; Byford S; Barrett B
    Health Technol Assess; 2017 Sep; 21(50):1-58. PubMed ID: 28877841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive-Behavioral Therapy to Alleviate Treatment-Induced Menopausal Symptoms in Women With Breast Cancer: A Systematic Review.
    Chang YC; Hu WY; Chang YM
    Cancer Nurs; 2021 Sep-Oct 01; 44(5):411-418. PubMed ID: 32925181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept.
    Moayeri F; Dunt D; Hsueh YA; Doyle C
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):331-340. PubMed ID: 30324818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cluster randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of classroom-based cognitive-behavioural therapy (CBT) in reducing symptoms of depression in high-risk adolescents.
    Stallard P; Phillips R; Montgomery AA; Spears M; Anderson R; Taylor J; Araya R; Lewis G; Ukoumunne OC; Millings A; Georgiou L; Cook E; Sayal K
    Health Technol Assess; 2013 Oct; 17(47):vii-xvii, 1-109. PubMed ID: 24172024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study protocol of a multicentre randomised controlled trial of self-help cognitive behaviour therapy for working women with menopausal symptoms (MENOS@Work).
    Hunter MS; Hardy C; Norton S; Griffiths A
    Maturitas; 2016 Oct; 92():186-192. PubMed ID: 27621258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).
    Chernyak N; Petrak F; Plack K; Hautzinger M; Müller MJ; Giani G; Icks A
    BMC Geriatr; 2009 Jul; 9():25. PubMed ID: 19570236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of a randomized trial to treat depression among Latinos.
    Kafali N; Cook B; Canino G; Alegria M
    J Ment Health Policy Econ; 2014 Jun; 17(2):41-50. PubMed ID: 25153092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial.
    Creswell C; Violato M; Fairbanks H; White E; Parkinson M; Abitabile G; Leidi A; Cooper PJ
    Lancet Psychiatry; 2017 Jul; 4(7):529-539. PubMed ID: 28527657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial.
    Goranitis I; Bellanca L; Daley AJ; Thomas A; Stokes-Lampard H; Roalfe AK; Jowett S
    PLoS One; 2017; 12(9):e0184328. PubMed ID: 28949974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome.
    Severens JL; Prins JB; van der Wilt GJ; van der Meer JW; Bleijenberg G
    QJM; 2004 Mar; 97(3):153-61. PubMed ID: 14976272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.